Hospital Corp of China Ltd 2018 AR2
The report highlights Hospital Corporation of China Limited's strategic expansion in 2018, including the acquisitions of Jiande Hexu, Cixi Hongai, and Oriental Ally, which significantly expanded its medical network in the Yangtze River Delta region. The company's revenue increased by 124.7% year-on-year to RMB 383.6 million, driven by these acquisitions and increased management fees. The Group managed, owned, and/or founded six hospitals, recording over 2.2 million outpatient visits and 87,334 inpatient visits. Additionally, the company implemented key management systems across its hospitals to improve operational efficiency and clinical quality.
Company: Hospital Corp of China Ltd
Sector: Healthcare & social services
Country: China
Year: 2018
Type: AR2
Pages: 195
Back to company
Hospital Corp of China Ltd
Annual Report
The report highlights Hospital Corporation of China Limited's strategic expansion in 2018, including the acquisitions of Jiande Hexu, Cixi Hongai, and Oriental Ally, which significantly expanded its medical network in the Yangtze River Delta region. The company's revenue increased by 124.7% year-on-year to RMB 383.6 million, driven by these acquisitions and increased management fees. The Group managed, owned, and/or founded six hospitals, recording over 2.2 million outpatient visits and 87,334 inpatient visits. Additionally, the company implemented key management systems across its hospitals to improve operational efficiency and clinical quality.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
Jan 1, 2018 - Dec 31, 2018
Fiscal Year
2018
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Water Consumption
Workplace Fatalities
Employees